Index S&P 500
P/E 33.19
EPS (ttm) 3.17
Insider Own 0.72%
Shs Outstand 1.73B
Perf Week 3.15%
Market Cap 183.08B
Forward P/E 20.46
EPS next Y 5.14
Insider Trans -0.73%
Shs Float 1.73B
Perf Month 0.34%
Income 5.54B
PEG 4.10
EPS next Q 1.20
Inst Own 79.17%
Short Float 0.62%
Perf Quarter -1.52%
Sales 40.73B
P/S 4.50
EPS this Y 4.91%
Inst Trans 0.27%
Short Ratio 1.77
Perf Half Y -6.41%
Book/sh 22.31
P/B 4.72
EPS next Y 10.41%
ROA 7.67%
Short Interest 10.75M
Perf Year -7.75%
Cash/sh 3.82
P/C 27.53
EPS next 5Y 8.10%
ROE 14.80%
52W Range 89.67 - 121.64
Perf YTD -4.39%
Dividend Est. 2.16 (2.06%)
P/FCF 37.19
EPS past 5Y 19.65%
ROI 10.78%
52W High -13.48%
Beta 0.71
Dividend TTM 2.16 (2.05%)
Quick Ratio 1.11
Sales past 5Y 6.10%
Gross Margin 57.86%
52W Low 17.36%
ATR (14) 2.13
Dividend Ex-Date Jul 15, 2024
Current Ratio 1.60
EPS Y/Y TTM -2.49%
Oper. Margin 16.33%
RSI (14) 53.49
Volatility 2.21% 1.99%
Employees 114000
Debt/Eq 0.38
Sales Y/Y TTM 1.24%
Profit Margin 13.61%
Recom 1.69
Target Price 124.49
Option/Short Yes / Yes
LT Debt/Eq 0.32
EPS Q/Q -5.00%
Payout 63.81%
Rel Volume 1.40
Prev Close 105.96
Sales Surprise 0.08%
EPS Surprise 3.17%
Sales Q/Q 4.00%
Earnings Jul 18 BMO
Avg Volume 6.07M
Price 105.24
SMA20 1.69%
SMA50 1.29%
SMA200 -1.41%
Trades
Volume 8,472,205
Change -0.68%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-24 Initiated
Goldman
Buy
$121
Jul-21-23 Upgrade
Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated
Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated
UBS
Buy
$117 → $130
Apr-20-23 Reiterated
Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated
JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated
Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated
Barclays
Overweight
$125 → $127
Mar-29-23 Initiated
UBS
Buy
$117
Oct-26-22 Initiated
Mizuho
Neutral
$105
Oct-18-22 Initiated
Barclays
Overweight
$118
Oct-12-22 Initiated
Jefferies
Hold
$110
Jul-06-22 Initiated
Wolfe Research
Underperform
$95
Mar-02-22 Resumed
BofA Securities
Buy
$140
Jan-27-22 Reiterated
UBS
Buy
$138 → $142
Jan-27-22 Reiterated
Raymond James
Outperform
$150 → $143
Jan-27-22 Reiterated
Morgan Stanley
Overweight
$157 → $151
Jan-27-22 Reiterated
Credit Suisse
Outperform
$138 → $139
Dec-10-21 Initiated
RBC Capital Mkts
Outperform
$146
Show Previous Ratings
Today 05:27AM
Jul-25-24 12:30PM
(The Wall Street Journal)
07:00AM
Jul-24-24 09:00AM
08:00AM
03:22AM
Loading…
03:22AM
Jul-20-24 08:45PM
07:00AM
Jul-19-24 12:33PM
(The Wall Street Journal)
03:11AM
(Thomson Reuters StreetEvents)
Jul-18-24 06:16PM
04:17PM
(Investor's Business Daily)
03:00PM
02:34PM
01:57PM
01:39PM
Loading…
01:39PM
11:55AM
11:06AM
10:32AM
09:54AM
09:30AM
08:45AM
07:43AM
(Investor's Business Daily)
07:42AM
(Associated Press Finance)
07:32AM
07:30AM
06:01AM
Jul-13-24 11:00AM
Jul-11-24 10:28AM
09:30AM
09:00AM
Loading…
09:00AM
08:00AM
Jul-10-24 03:22PM
Jul-09-24 06:00PM
Jul-04-24 07:03PM
03:54PM
06:35AM
Jul-02-24 04:45PM
Jul-01-24 06:00AM
Jun-28-24 07:28PM
09:00AM
Jun-27-24 08:00AM
Jun-26-24 08:00AM
06:48AM
Jun-25-24 06:00PM
Jun-24-24 11:40AM
11:25AM
09:30AM
Jun-21-24 12:24PM
11:13AM
11:10AM
11:08AM
11:02AM
10:58AM
10:56AM
Jun-20-24 11:02AM
09:25AM
08:05AM
05:15AM
Jun-18-24 03:51PM
Jun-17-24 06:00PM
09:00AM
Jun-14-24 12:01PM
Jun-13-24 02:26PM
Jun-12-24 09:43AM
09:33AM
08:15AM
08:00AM
07:45AM
Jun-11-24 05:50PM
01:02PM
09:45AM
08:15AM
Jun-10-24 04:04PM
(Investor's Business Daily)
02:55PM
Jun-09-24 09:00AM
Jun-07-24 05:16PM
07:10AM
Jun-06-24 02:32PM
02:25PM
09:30AM
Jun-05-24 05:50PM
09:00AM
Jun-03-24 03:51PM
09:00AM
May-31-24 12:20PM
12:18PM
May-30-24 05:50PM
02:33PM
08:00AM
05:50AM
May-29-24 04:58PM
02:30PM
May-28-24 06:45AM
May-27-24 12:46PM
12:39PM
May-24-24 05:50PM
May-22-24 05:17PM
09:31AM
May-21-24 09:30AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT May 10 '24 Option Exercise 47.00 10,097 474,559 221,438 May 14 05:35 PM Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT May 10 '24 Sale 104.57 10,097 1,055,819 211,341 May 14 05:35 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT May 07 '24 Sale 106.25 22,852 2,428,119 61,462 May 08 05:00 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 963 114,116 125,697 Mar 04 07:18 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 853 101,080 184,806 Mar 04 06:39 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 801 94,918 62,968 Mar 04 07:14 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 694 82,239 84,314 Mar 04 06:50 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 676 80,106 91,260 Mar 04 07:09 PM MCCOY JOHN A. JR. VICE PRESIDENT Mar 01 '24 Sale 118.50 472 55,932 18,760 Mar 04 07:05 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Option Exercise 59.94 12,500 749,250 91,204 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Sale 120.00 12,500 1,500,000 78,704 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Jan 29 '24 Option Exercise 50.80 42,500 2,158,950 90,027 Jan 31 05:30 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Jan 29 '24 Sale 112.50 42,500 4,781,250 65,027 Jan 31 05:30 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Dec 14 '23 Option Exercise 44.40 15,000 666,000 80,027 Dec 18 05:36 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Dec 14 '23 Sale 108.00 15,000 1,620,000 65,027 Dec 18 05:36 PM STARKS DANIEL J Director Oct 26 '23 Sale 94.05 50,000 4,702,526 6,725,316 Oct 30 04:58 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Aug 08 '23 Option Exercise 38.40 5,000 192,000 75,427 Aug 10 06:31 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Aug 08 '23 Sale 105.03 10,400 1,092,297 65,027 Aug 10 06:31 PM STARKS DANIEL J Director Jul 27 '23 Sale 113.76 50,000 5,688,189 6,775,316 Jul 28 05:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite